Humoral and cellular immune response to mRNA SARS-CoV-2 BNT162b2 vaccine in adolescents with rheumatic diseases

• Asıl Yazarlar: Clara Udaondo (Yazar), Carmen Cámara (Yazar), Laura Miguel Berenguel (Yazar), Rosa Alcobendas Rueda (Yazar), Celia Muñoz Gómez (Yazar), Claudia Millán Longo (Yazar), Blanca Díaz - Delgado (Yazar), Iker Falces-Romero (Yazar), Mariana Díaz Almirón (Yazar), Jordi Ochando (Yazar), Ana Méndez - Echevarría (Yazar), Agustín Remesal Camba (Yazar), Cristina Calvo (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2022-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background Data about safety and efficacy of the mRNA SARS-CoV-2 vaccine in adolescents with rheumatic diseases (RD) is scarce and whether these patients generate a sufficient immune response to the vaccine remains an outstanding question. Objective To evaluate safety and humoral and cellul...